Elife Holdings Limited (the “Company,” together with its subsidiaries, the “Group”), listed on the Hong Kong Stock Exchange (stock code: 223), announced its unaudited interim results for the six months ended 30 September 2025. During the reporting period, the Group recorded key changes in revenue composition and reversed from a loss to a profit position, despite a challenging market environment.
According to the announcement, the Group’s total revenue decreased by 49% to approximately HK$60.93 million (compared with HK$119.53 million for the same period in 2024). The drop was attributed mainly to the redirection of resources amid trading suspension and economic headwinds, yet gross profit declined at a slower rate from HK$9.50 million to HK$6.58 million, raising the gross profit margin from 7.9% to 10.8%. The improvement reflected optimization of costs and rebates in its brand promotion business.
During the reporting period, brand promotion services contributed approximately 89% of total revenue, amounting to HK$53.99 million. Overall, the Group reported a profit attributable to shareholders of about HK$4.37 million for continuing operations, compared with a loss of HK$29.15 million in the corresponding period last year. Management noted effective cost-controls and efforts to expand digital capabilities as factors stabilizing performance.
The Group’s supply chain business, comprising comprehensive services in brand management, promotion, and distribution, remained the primary revenue contributor, emphasizing expansion in branded goods and consumer products. Its daily cleaning and anti-epidemic products business posted reduced sales but remains integral to the Group’s product mix. Operations in licensed branded consumer goods are being scaled back.
Management stated that the Group will continue to follow its “easier life and better livelihood” philosophy, with plans to strengthen digitalized brand promotion and supply chain services. The interim report indicates that Elife Holdings will proceed with cost optimization, strategic partnerships, and a cautious expansion in both domestic and overseas markets.
As at 30 September 2025, the Company’s cash and cash equivalents stood at HK$23.53 million. The Board has not recommended any interim dividend for the reporting period.